Litcius/Paper detail

Point-of-Care Gastric Ultrasound to Identify a Full Stomach on a Diabetic Patient Taking a Glucagon-Like Peptide 1 Receptor Agonist

Laura Girón‐Arango, Anahi Perlas

2024A&A Practice18 citationsDOI

Abstract

Recently, there has been increased interest in the relationship between glucagon-like peptide 1 (GLP-1) receptor agonists, delayed gastric emptying, and subsequent risk of aspiration in the perioperative setting. This case illustrates how gastric ultrasound can be incorporated at the bedside to assess the risk of aspiration in patients taking this type of medication for diabetes or weight loss and guide clinical management and anesthetic technique to reduce the risk of aspiration.

Topics & Concepts

MedicineAgonistGlucagon-like peptide 1 receptorType 2 diabetesGastric emptyingDiabetes mellitusGlucagon-like peptide-1PerioperativeStomachInternal medicineGastroenterologyReceptorSurgeryEndocrinologyEnhanced Recovery After SurgeryGastroesophageal reflux and treatmentsGastric Cancer Management and Outcomes
Point-of-Care Gastric Ultrasound to Identify a Full Stomach on a Diabetic Patient Taking a Glucagon-Like Peptide 1 Receptor Agonist | Litcius